Form 8-K - Current report:
SEC Accession No. 0001641172-25-023580
Filing Date
2025-08-13
Accepted
2025-08-13 17:13:31
Documents
13
Period of Report
2025-07-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 34843
  Complete submission text file 0001641172-25-023580.txt   196500

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ppcb-20250731.xsd EX-101.SCH 3011
3 XBRL LABEL FILE ppcb-20250731_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE ppcb-20250731_pre.xml EX-101.PRE 22356
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3443
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)